OCULUS study: Virtual reality-based education in daily clinical practice

Abstract

Background: Atrial fibrillation (AF) is associated with high risk of stroke and other thromboembolic complications. The OCULUS study aimed to evaluate the effectiveness of the three-dimensional (3D) movie in teaching patients about the consequences of AF and pharmacological stroke prevention.

Methods: The study was based on a questionnaire and included 100 consecutive patients (38% women, 62% with AF history). Using the oculus glasses and a smartphone, a 3D movie describing the risk of stroke in AF was shown. Similar questions were asked immediately after, 1 week and 1 year after the projection.

Results: Before the projection 22/100 (22.0%) declared stroke a consequence of AF, while immediately after 83/100 (83.0%) (p < 0.0001) patients declared this consequence. Seven days after, stroke as AF consequence was chosen by 74/94 (78.7%) vs. 22/94 (23.4%) when compared to the baseline knowledge; p < 0.0001, a similar trend was also observed in 1-year follow-up (64/90 [71.1%] vs. 21/90 [23.3%]; p < 0.0001). Before the projection 88.3% (83/94) patients responded, that drugs may reduce the risk of stroke, and after 1 week the number of patients increased to (94/94 [100%]; p = 0.001). After 1 year 87/90 (96.7%) answered that drugs may diminish the risk of stroke (p = 0.02 in comparison to the baseline survey 78/90 [86.7%]). Use of oral anticoagulation to reduce the risk of stroke was initially chosen by 66/94 (70.2%), by 90/94 (95.7%; p < 0.0001) 7 days after and by 83/90 (92.2%; p < 0.0001) 1 year after.

Conclusions: 3D movie is an effective tool in transferring knowledge about the consequences of AF and the pivotal role of oral anticoagulation in stroke prevention.

Trial registration: ClinicalTrials.gov, NCT03104231. Registered on 28 March 2017.

Keywords: atrial fibrillation; education; stroke; three-dimensional movie; virtual reality.

Conflict of interest statement

Conflict of interest: None declared

Figures

Figure 1

Percentages of patients declaring stroke a dangerous consequence of atrial fibrillation; A. Immediately after the projection; B. One week after the projection; C. One year after the projection.

Figure 2

Percentages of patients choosing oral anticoagulants as drugs which reduce the risk of stroke; A. One week after projection; B. One year after projection.

Figure 3

Percentages of patients who declare taking oral anticoagulants previously; A. One week after projection; B. One year after projection.